Filer Snapshot

MWG Caph Ltd

CIK 0002111120. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

2

Latest filing

11 May 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: 13F-HR for Q4 2025. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

BEAM

$35.12M reported value

Open holding

13D/G large stake

LYEL

31 Mar 2026 · 4.3% ownership

Open 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Schedule 13D/G

SCHEDULE 13G/A filed on 11 May 2026 for CIK 0002111120.

View source filing
Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Parsed SEC ownership signals

Parsed SEC ownership coverage

These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.

13F portfolio$72.37M

Quarterly institutional holdings reported on Form 13F; not total AUM.

Latest reported 13F value

13F
$72.37M

Reported market value from the latest parsed Form 13F information table; this is not total assets under management.

Source: SEC Form 13FScope: U.S.-listed equity holdings

Largest 13F holdings

13F
BEAM LYEL PRME

Largest symbols in the latest parsed Form 13F information table.

Freshness: Latest parsed 13F period

Largest 13F holdings

Largest symbols in the latest parsed Form 13F information table.

BEAM LYEL PRME

Largest active 13G stakes

Passive or institutional large-stake positions disclosed in parsed Schedule 13G filings.

LYEL
How to read these SEC ownership signals
  • Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
  • Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
  • Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
Morton House, Government Road, Po Box 583, Charlestown, NEV 0001
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 2 profile fields available
Incorporated in
Saint Kitts and Nevis
Fiscal year end
31 December

Filer intelligence

What SEC filings say about MWG Caph Ltd

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Latest parsed 13F shows $72.37M across 3 reported holdings for Q4 2025.
  • Largest parsed 13F holding: BEAM at $35.12M.
  • 1 recent 13D/G stake row found; top row is LYEL at 4.3% ownership.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio 3 rows

Quarterly institutional portfolio holdings.

Open
13D/G stakes 1 rows

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 No rows yet

Officer, director, and 10% owner holdings or transactions.

Open

Top parsed 13F holdings

Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.

Q4 2025 - 17 Feb 2026

Top 5 concentration

100%

Share of latest parsed 13F value represented by the visible holdings below.

Top 5 reported value

$72.37M

Compared with $72.37M total 13F value.

Top 5 net change

$0

Position-value change inside the visible top holdings only.

13F concentration map

A simple visual split of the latest parsed 13F portfolio.

BEAM LYEL PRME

BEAM

48.5%

Beam Therapeutics Inc

$35.12M

LYEL

42.9%

Lyell Immunopharma Inc

$31.03M

PRME

8.6%

Prime Medicine Inc

$6.22M

13D/G large-stake context

LYEL

31 Mar 2026 · Common Stock, $0.0001 par value per share

4.3%

Latest update

What changed recently for MWG Caph Ltd

New filing available

Latest Schedule 13D/G period: 31 Mar 2026. Open the source-backed page to inspect the fresh filing or facts context.

Update date

11 May 2026

Page type

Filer profile

Latest period

31 Mar 2026

Schedule 13D/G context is visible from filings filed on 11 May 2026.

Benchmark Context

Benchmark context for this company

MWG Caph Ltd has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest Schedule 13D/G period: 31 Mar 2026. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

SEC filing record

CIK 0002111120 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
2
First seen
17 Feb 2026
Latest filing
11 May 2026
Entity
Company

Observed form types

13F-HR SCHEDULE 13G/A

Latest Filings

Showing the latest 2 of 2 SEC filings for MWG Caph Ltd.

SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
11 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
17 Feb 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .